Review
Copyright ©The Author(s) 2025.
World J Cardiol. Feb 26, 2025; 17(2): 102308
Published online Feb 26, 2025. doi: 10.4330/wjc.v17.i2.102308
Table 1 Acid sphingomyelinase/ceramide functional inhibitors
Serial number
FIASMAs
Current functional or therapeutic disease
Potential therapeutic metabolic disease
1AmitriptylineDepressionDiabetic cardiomyopathy
2DesipramineDepressionInsulin resistance. Diabetes
3DoxepinDepressionDiabetes
4ImipramineDepressionDiabetic cardiomyopathy
5Alpha-mangostinAnti-cancer, antibacterial, anti-inflammation, antioxidantVascular endothelial injury. Cardiovascular disease
6EmpagliflozinDiabetesCardiovascular disease